RadNet, Inc. (RDNT): Total Assets
$3.76B
As of 2025-12-31
$4.23B
As of 2026-06-30
+15.6%
3-year compound annual growth
+16.0%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.76B | +14.4% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $3.29B | +22.2% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $2.69B | +10.5% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $2.43B | +18.2% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $2.06B | +15.2% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $1.79B | +8.5% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $1.65B | +48.5% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $1.11B | +27.7% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $868.98M | +2.3% | 2019-03-18, Balance as of period end |
| 2016-12-31 | $849.48M | n/m | 2018-03-19, Balance as of period end |
| 2015-12-31 | $35.49M | -4.9% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $37.32M | -8.2% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $40.65M | -3.4% | 2016-03-30, Balance as of period end |
| 2012-12-31 | $42.10M | -4.1% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $43.90M | -91.9% | 2013-11-13, Balance as of period end |
| 2010-12-31 | $539.51M | n/a | 2012-03-13, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| RadNet, Inc. (RDNT) | 2025-12-31 | $3.76B | +14.4% |
| Natera, Inc. (NTRA) | 2025-12-31 | $2.40B | +44.4% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.72B | -24.1% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $16.23B | +0.4% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
Compare RDNT, NTRA, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗